Management of oesophageal cancer

Indian Journal of Surgery

Volumn 71, Issue 6, 2009, Pages 317-325

  Tong, Daniel K H ^a   Law, Simon ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Multimodality treatment; Oesophageal cancer; Oesophagectomy

Indexed keywords

EID: 74849115607     PISSN: 09722068     EISSN: 09739793     Source Type: Journal    
DOI: 10.1007/s12262-009-0087-3     Document Type: Review

References (61)

1. Parkin DM, Bray F, Ferlay J, Pisani P (2005) Global cancer statistics, 2002. CA Cancer J Clin 55: 74-108.
2. Gupta NM, Jindal R, Prakash O, Gupta R, Bhasin DK (2001) Comparison of the clinical profile and outcome for squamous cell carcinoma and adenocarcinoma of the distal esophagus and cardia in India. Surg Today 31: 400-404.
3. Devesa SS, Blot WJ, Fraumeni JF Jr (1998) Changing patterns in the incidence of esophageal and gastric carcinoma in the United States. Cancer 83: 2049-2053.
4. Law S, Wong J (2002) Changing disease burden and management issues for esophageal cancer in the Asia-Pacific region. J Gastroenterol Hepatol 17: 374-381.
5. Peters JH, Hagen JA, DeMeester SR (2004) Barrett's esophagus. J Gastrointest Surg 8: 1-17.
6. Graham DY (2003) The changing epidemiology of GERD: Geography and Helicobacter pylori. Am J Gastroenterol 98: 1462-1470.
7. Cherian JV, Sivaraman R, Muthusamy AK, Jayanthi V (2007) Carcinoma of the esophagus in Tamil Nadu (South India): 16-year trends from a tertiary center. J Gastrointestin Liver Dis 16: 245-249.
8. Li L, Lu F, Zhang S (1996) Analysis of cancer modality and distribution in China from year 1990 through 1992- an epidemiologic study. Zhonghua Zhong Liu Za Zhi 18: 403-407.
9. He YT, Hou J, Qiao CY, et al. (2003) An analysis of esophageal cancer incidence in Cixian county from 1974 to 1996. World J Gastroenterol 9: 209-213.
10. Gao H, Wang LD, Zhou Q, Hong JY, Huang TY, Yang CS (1994) p53 tumour suppressor gene mutation in early esophageal precancerous lesions and carcinoma among highrisk populations in Henan, China. Cancer Res 54: 4342-4346.
11. Li MH, Li P, Li PJ (1980) Recent progress in research on esophageal cancer in China. Adv Cancer Res 33: 173-249.
12. Phukan RK, Ali MS, Chetia CK, Mahanta J (2001) Betel nut and tobacco chewing; potential risk factors of cancer of oesophagus in Assam, India. Br J Cancer 85: 661-667.
13. Khuroo MS, Zargar SA, Mahajan R, Banday MA (1992) High incidence of oesophageal and gastric cancer in Kashmir in a population with special personal and dietary habits. Gut 33: 11-15.
14. Lee CH, Lee JM, Wu DC, et al. (2005) Independent and combined effects of alcohol intake, tobacco smoking and betel quid chewing on the risk of esophageal cancer in Taiwan. Int J Cancer 113: 475-482.
15. Murtaza I, Mushtaq D, Margoob MA, et al. (2006) A study on p53 gene alterations in esophageal squamous cell carcinoma and their correlation to common dietary risk factors among population of the Kashmir valley. World J Gastroenterol 12: 4033-4037.
16. Chitra S, Ashok L, Anand L, Srinivasan V, Jayanthi V (2004) Risk factors for esophageal cancer in Coimbatore, southern India: a hospital-based case-control study. Indian J Gastroenterol 23: 19-21.
17. Dawsey SM, Shen Q, Nieberg RK, et al. (1997) Studies of esophageal balloon cytology in Linxian, China. Cancer Epidemiol Biomarkers Prev 6: 121-130.
18. Nabeya K, Hanaoka T, Onozawa K, Ri S, Nyumura T, Kaku C (1990) Early diagnosis of esophageal cancer. Hepatogastroenterology 37: 368-370.
19. Wang GQ, Jiao GG, Chang FB, et al. (2004) Long-term results of operation for 420 patients with early squamous cell esophageal carcinoma discovered by screening. Ann Thorac Surg 77: 1740-1744.
20. Peters JH, Clark GW, Ireland AP, Chandrasoma P, Smyrk TC, DeMeester TR (1994) Outcome of adenocarcinoma arising in Barrett's esophagus in endoscopically surveyed and nonsurveyed patients. J Thorac Cardiovasc Surg 108: 813-821.
21. American Joint Committee on Cancer (2009) Esophagus. In: AJCC Cancer Staging Manual. Springer Verlag, New York.
22. Rosch T (1995) Endosonographic staging of esophageal cancer: a review of literature results. Gastrointest Endosc Clin N Am 5: 537-547.
23. Reed CE, Mishra G, Sahai AV, Hoffman BJ, Hawes RH (1999) Esophageal cancer staging: improved accuracy by endoscopic ultrasound of celiac lymph nodes. Ann Thorac Surg 67: 319-321.
24. Luketich JD, Schauer PR, Melttumourr CC, et al. (1997) Role of positron emission tomography in staging esophageal cancer. Ann Thorac Surg 64: 765-769.
25. Flamen P, Lerut A, van Cutsem E, et al. (2000) Utility of positron emission tomography for the staging of patients with potentially operable esophageal carcinoma. J Clin Oncol 18: 3202-3210.
26. Lerut T, Flamen P, Ectors N, et al. (2000) Histopathologic validation of lymph node staging with FDG-PET scan in cancer of the esophagus and gastroesophageal junction: A prospective study based on primary surgery with extensive lymphadenectomy. Ann Surg 232: 743-752.
27. Luketich JD, Friedman DM, Weigel TL, et al. (1999) Evaluation of distant metastases in esophageal cancer: 100 consecutive positron emission tomography scans. Ann Thorac Surg 68: 1133-1136.
28. Swisher SG, Maish M, Erasmus JJ, et al. (2004) Utility of PET, CT, and EUS to identify pathologic responders in esophageal cancer. Ann Thorac Surg 78: 1152-1160.
29. Earlam R, Cunha-Melo JR (1980) Oesophageal squamous cell carcinoma: I. A critical review of surgery. Br J Surg 67: 381-390.
30. Muller JM, Erasmi H, Stelzner M, Zieren U, Pichlmaier H (1990) Surgical therapy of oesophageal carcinoma. Br J Surg 77: 845-857.
31. Birkmeyer JD, Siewers AE, Finlayson EV, et al. (2002) Hospital volume and surgical mortality in the United States. N Engl J Med 346: 1128-1137.
32. Birkmeyer JD, Stukel TA, Siewers AE, Goodney PP, Wennberg DE, Lucas FL (2003) Surgeon volume and operative mortality in the United States. N Engl J Med 349: 2117-2127.
33. Law S, Kwong DL, Kwok KF, et al. (2003) Improvement in treatment results and long-term survival of patients with esophageal cancer: impact of chemoradiation and change in treatment strategy. Ann Surg 238: 339-347.
34. Altorki N, Kent M, Ferrara C, Port J (2002) Three-field lymph node dissection for squamous cell and adenocarcinoma of the esophagus. Ann Surg 236: 177-183.
35. Ando N, Ozawa S, Kitagawa Y, Shinozawa Y, Kitajima M (2000) Improvement in the results of surgical treatment of advanced squamous esophageal carcinoma during 15 consecutive years. Ann Surg 232: 225-232.
36. Siewert JR, Stein HJ, Feith M, Bruecher BL, Bartels H, Fink U (2001) Histologic tumour type is an independent prognostic parameter in esophageal cancer: Lessons from more than 1, 000 consecutive resections at a single center in the Western world. Ann Surg 234: 360-367.
37. Wouters MW, Karim-Kos HE, le Cessie S, et al. (2009) Centralization of esophageal cancer surgery: does it improve clinical outcome? Ann Surg Oncol 16: 1789-1798.
38. Lagarde SM, Maris AK, de Castro SM, Busch OR, Obertop H, van Lanschot JJ (2007) Evaluation of O-POSSUM in predicting in-hospital mortality after resection for oesophageal cancer. Br J Surg 94: 1521-1526.
39. Law SY, Fok M, Wong J (1994) Risk analysis in resection of squamous cell carcinoma of the esophagus. World J Surg 18: 339-346.
40. Law S, Wong KH, Kwok KF, Chu KM, Wong J (2004) Predictive factors for postoperative pulmonary complications and mortality after esophagectomy for cancer. Ann Surg 240: 791-800.
41. Bartels H, Stein HJ, Siewert JR (1998) Preoperative risk analysis and postoperative mortality of oesophagectomy for resectable oesophageal cancer. Br J Surg 85: 840-844.
42. Orringer MB, Marshall B, Iannettoni MD (1999) Transhiatal esophagectomy: clinical experience and refinements. Ann Surg 230: 392-400.
43. Katariya K, Harvey JC, Pina E, Beattie EJ (1994) Complications of transhiatal esophagectomy. J Surg Oncol 57: 157-163.
44. Omloo JM, Lagarde SM, Hulscher JB, et al. (2007) Extended transthoracic resection compared with limited transhiatal resection for adenocarcinoma of the mid/distal esophagus: five-year survival of a randomised clinical trial. Ann Surg 246: 992-1000.
45. Cuschieri A, Shimi S, Banting S (1992) Endoscopic oesophagectomy through a right thoracoscopic approach. J R Coll Surg Edinb 37: 7-11.
46. Qureshi I, Nason KS, Luketich JD (2008) Is minimally invasive esophagectomy indicated for cancer? Expert Rev Anticancer Ther 8: 1449-1460.
47. Law SY, Fok M, Wei WI, et al. (2000) Thoracoscopic esophageal mobilization for pharyngolaryngoesophagectomy. Ann Thorac Surg 70: 418-422.
48. Osugi H, Takemura M, Higashino M, Takada N, Lee S, Kinoshita H (2003) A comparison of video-assisted thoracoscopic oesophagectomy and radical lymph node dissection for squamous cell cancer of the oesophagus with open operation. Br J Surg 90: 108-113.
49. Smithers BM, Gotley DC, McEwan D, Martin I, Bessell J, Doyle L (2001) Thoracoscopic mobilization of the esophagus. A 6 year experience. Surg Endosc 15: 176-182.
50. Law S, Fok M, Chu KM, Wong J (1997) Thoracoscopic esophagectomy for esophageal cancer. Surgery 122: 8-14.
51. Osugi H, Takemura M, Higashino M, et al. (2003) Learning curve of video-assisted thoracoscopic esophagectomy and extensive lymphadenectomy for squamous cell cancer of the thoracic esophagus and results. Surg Endosc 17: 515-519.
52. Akiyama H, Tsurumaru M, Udagawa H, Kajiyama Y (1994) Radical lymph node dissection for cancer of the thoracic esophagus. Ann Surg 220: 364-372.
53. Peyre CG, Hagen JA, DeMeester SR, et al. (2008) The number of lymph nodes removed predicts survival in esophageal cancer: an international study on the impact of extent of surgical resection. Ann Surg 248: 549-556.
54. Rizk NP, Ishwaran H, Rice T, Chen LQ, Schipper P et al. (2009) Optimum lymphadenectomy for esophageal cancer. Ann Surg (In-press).
55. Medical Research Council Oesophageal Cancer Working Party (2002) Surgical resection with or without preoperative chemotherapy in oesophageal cancer: a randomized controlled trial. Lancet 359(9319): 1727-1733.
56. Petrasch S, Welt A, Reinacher A, Graeven U, Konig M, Schmiegel W (1998) Chemotherapy with cisplatin and paclitaxel in patients with locally advanced, recurrent or metastatic oesophageal cancer. Br J Cancer 78: 511-514.
57. Kok TC, Kerfhofs L, et al. (1998) Biweekly administration of cisplatin and increasing doses of paclitaxel in patients with advanced esophageal cancer. Proc Am Soc Clin Oncol 17 (Abstract 997).
58. Herskovic A, Martz K, al-Sarraf M, et al. (1992) Combined chemotherapy and radiotherapy compared with radiotherapy alone in patients with cancer of the esophagus. N Engl J Med 326: 1593-1598.
59. Cooper JS, Guo MD, Herskovic A, et al. (1999) Chemoradiotherapy of locally advanced esophageal cancer: long-term follow-up of a prospective randomised trial (RTOG 85-01). Radiation Therapy Oncology Group. JAMA 281: 1623-1627.
60. Law S, Wong J (2005) Current management of esophageal cancer. J Gastrointest Surg 9: 291-310.
61. Baron TH (2001) Expandable metal stents for the treatment of cancerous obstruction of the gastrointestinal tract. N Engl J Med 344: 1681-1687.